RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding

The mechanism underlying the RPTOR-promoted NSCLC-BM via the SPHK2/S1P/STAT3 signaling pathway. RPTOR regulated the transcriptional activation of the ceramidase SPHK2 by binding to the transcription factor YY1. SPHK2 catalyzed the degradation of ceramide to S1P. The latter, in turn, activated the STAT3 signaling pathway by binding to S1PR1 (solid lines), altering the microenvironment and enhancing the permeability of the BBB (dotted lines), resulting in the BM of NSCLC
RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding

Publication

RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding. (2024) Ying Lin, et al. J Exp Clin Cancer Res. 2024;43:1. Figure: F6.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates mTOR MTOR ncbigene_symbol MTOR 2475
Homo sapiens Primates RPTOR RPTOR ncbigene_symbol RPTOR 57521
Homo sapiens Primates YY1 YY1 ncbigene_symbol YY1 7528
Homo sapiens Primates SPHK2 SPHK2 ncbigene_symbol SPHK2 56848
Homo sapiens Primates S1P S1P ncbigene_synonym MBTPS1 8720
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774

Chemical mentions

Word Match MeSH Name ChEBI
ceramide ceramide an N-acylsphing-4-enine chebi:52639
ceramide ceramide an N-acylsphing-4-enine chebi:52639
ceramide ceramide an N-acylsphing-4-enine chebi:52639
ceramide ceramide an N-acylsphing-4-enine chebi:52639
S1P S1P (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate chebi:37550

Disease mentions

Word Match MeSH Name DOID